Aigen Investment Management’s Zimmer Biomet ZBH Stock Holding History

Aigen Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,721	Closed	-$618K	–	1025
2024 Q3	$618K	Sell	5,721 -2,010	-26%	-$219K	0.12%	254
2024 Q2	$839K	Buy	+7,731	New	+$911K	0.16%	170
2023 Q4	–	Sell	-11,610	Closed	-$1.3M	–	1130
2023 Q3	$1.3M	Buy	+11,610	New	+$1.47M	0.25%	103
2022 Q1	–	Sell	-18,581	Closed	-$2.24M	–	1157
2021 Q4	$2.24M	Buy	18,581 +4,163	+29%	+$545K	0.14%	197
2021 Q3	$2.05M	Buy	+14,418	New	+$2.12M	0.39%	71
2021 Q2	–	Sell	-4,314	Closed	-$670K	–	766
2021 Q1	$670K	Buy	+4,314	New	+$668K	0.09%	240

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Aigen Investment Management's ZBH Position: Q4 2024 in Review

Aigen Investment Management sold out of Zimmer Biomet (ZBH) in Q4 2024, closing a stake of 5,721 shares — an estimated $618K sold.

Aigen Investment Management first reported a position in ZBH in Q1 2021 and held it in 6 quarters. The position peaked at $2.24M in Q4 2021. 1,027 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

Aigen Investment Management reported no remaining Zimmer Biomet position as of Q4 2024 after selling out during the quarter.
Aigen Investment Management sold 5,721 Zimmer Biomet shares in Q4 2024, an estimated $618K.
Aigen Investment Management first reported a position in Zimmer Biomet in Q1 2021 and held it in 6 quarters.
Aigen Investment Management's Zimmer Biomet position peaked at $2.24M in Q4 2021.
1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on Aigen Investment Management's 13F filing for Q4 2024, filed 6 Feb 2025.